GB2105190A - Light-screen compositions - Google Patents

Light-screen compositions Download PDF

Info

Publication number
GB2105190A
GB2105190A GB08221133A GB8221133A GB2105190A GB 2105190 A GB2105190 A GB 2105190A GB 08221133 A GB08221133 A GB 08221133A GB 8221133 A GB8221133 A GB 8221133A GB 2105190 A GB2105190 A GB 2105190A
Authority
GB
United Kingdom
Prior art keywords
ester
light
methoxycinnamic acid
screen
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
GB08221133A
Other versions
GB2105190B (en
Inventor
Paul Albert Ochsner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Givaudan SA
Original Assignee
L Givaudan and Co SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L Givaudan and Co SA filed Critical L Givaudan and Co SA
Publication of GB2105190A publication Critical patent/GB2105190A/en
Application granted granted Critical
Publication of GB2105190B publication Critical patent/GB2105190B/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/37Esters of carboxylic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

Light-screen compositions contain a compound of the formula: <IMAGE> wherein R1 is hydrogen or C1-3-alkyl, R<2> is hydrogen or C1-7-alkyl, X is (-CH2)n or (-CH2OCH2-)p and m = 1-5, n = 0-4, and p = 1-3, in dissolved or dispersed form.

Description

SPECIFICATION Light-screen compositions The invention is concerned with novel light-screen compositions, which contain a compound of the formula
wherein R1 represents hydrogen of C1~3-alkyl, especially hydrogen or methyl, R2 represents hydrogen of C1~7-alkyl, especially methyl, X stands for the grouping (-CH2-)n or(-CH2OCH2-)p and m = 1-5, especially 1, n = 0-4, especially 0, and p = 1-3, especially 1 or 2, in dissolved or dispersed form. The invention is also concerned with the use of compounds of formula I in dissolved or dispersed form as light-screen agents.
As C13-alkyl groups there come into consideration methyl, ethyl, propyl and i-propyl. Methyl is preferred.
The C47 groups can also be straight-chain or branched-chain and thus can be, for example, butyl, i-butyl, amyl, hexyl, heptyl, etc.
Preferred compounds of formula I are: Propyleneglycol di-(p-methoxycinnamic acid) ester, 1,3-butyleneg 1 ,3-butyleneglycol di-(p-methoxycinnamic acid) ester and triethyleneglycol di-(p-methoxycinnamic acid) ester.
Other representative compounds of formula I are: Ethyleneglycol di-(p-methoxycinnamic acid) ester, trimethyleneglycol di-(p-methoxycinnamic acid) ester, 2,3-butyleneglycol di-(p-methoxycinnamic acid) ester, diethyleneglycol di-(p-methoxycinnamic acid) ester, glycerine tri-(p-methoxycinnamic acid) ester, dipropyleneglycol di-(p-methoxycinnamic acid) ester, 2-methyl-2,4-pentanediol di-(p-methoxycinnamic acid) ester, 1,4-butanediol di-(p-methoxycinnamic acid) ester, 1,5-pentanediol di-(p-methoxycinnamic acid) ester, 1,6-hexanediol di-(p-methoxycinnamic acid) ester, 2,5-hexanediol di-(p-methoxycinnamic acid) ester and sorbitol hexa-(p-methoxycinnamic acid) ester.
The compounds of formula I absorb the erythema-producing ultraviolet rays of the sun (between 280 and 320 mp) in a pronounced manner, i.e. they keep these rays away from the living epidermis cells. The compounds of formula I can accordingly be used as light-screen agents. The invention is also concerned with a process for the manufacture of a light-screen composition, which method comprises incorporating a compound of formula I into a base which is usual in cosmetics.
The cosmetic base usual for light-screen agents in the scope of the present invention can be any usual preparation which corresponds to the cosmetic requirements; for example, creams, emulsions, salves, (alcoholic) solutions, sprays, sticks, milks and the like, see also G.A. Nowak, Die Kosmetischen Präparate, 1 sot Edition 1969, 2nd Edition 1975 (Augsburg), which literature reference refers in detail to the solvents (in the present case especially polar solvents), solubilizers, emulsifiers, thickening agents, odorant substances, preserving agents, colouring substances and other possible adjuvant substances which can be used in the manufacture of cosmetic preparations. The light-screen action is, of course, also dependent on the base which is used.The intensity of the light-screen action also depends, in the case of the same base, on the concentration of active ingredient. Suitable concentrations are, for example, between 1-6%, preferably between 2-4%, especially about 3%, of a compound of formula I in the cosmetic preparation.
On the basis of their lipophility, the compounds I can be incorporated in sufficient concentration in oil-containing and fat-containing cosmetic preparations; They have more than optimum properties with regard to adequate fat solubility and pronounced absorption of the UV B-radiation. Furthermore, the compounds I as neutral substances have good skin compatibility.
The cosmetic preparations can also contain other light-absorbing substances, for example, other UV A-filters and/or UV B-filters.
Examples of UV A-filters are: 4-Isopropyl-dibenzoylmethane, 4-(1,1 -dimethylethyl)-4'-methoxydibenzoylmethane, dianisoylmethane and hydroxybenzophenones (e.g. 2,4-dihydroxybenzophenone).
As UV B-filters, i.e. as substances having absorption maxima between about 290 and 320 nm, there can be named usual UV B-filters such as, for example, the following organic compounds belonging to the most diverse classes of substances: (1) Derivatives of p-aminobenzoic acid such as, for example, ethyl p-aminobenzoate and other esters such as propyl p-aminobenzoate, butyl p-aminobenzoate and isobutyl p-aminobenzoate, ethyl pdimethylaminobenzoate, glyceryl p-aminobenzoate and amyl p-dimethylaminobenzoate.
(2) Derivatives of cinnamic acid such as, for example, 2-ethoxyethyl p-methoxycinnamate, 2-ethylhexyl p-methoxycinnamate, p-methoxycinnamic acid ester mixtures, cinnamic acid esters and ammonium salts of p-methoxycinnamic acid.
(3) Dibenzalazine.
(4) Heterocyclic nitrogen compounds such as derivatives of 2-phenylbenzimidazole (e.g. 2- phenylbenzimidazole-5-sulphonic acid).
(5) Derivatives of salicylic acid such as, for example, menthyl salicylate, homomenthyl salicylate and phenyl salicylate.
(6) Derivatives of benzophenone such as, for example, 4-phenylbenzophenone, isooctyl 4phenyl benzophenone-2-carboxylate and 2-hydroxy-4-methoxybenzophenone-5-su Iphonic acid.
(7) Derivatives of coumarin, such as, for example, 7-oxycoumarin, ss-umbelliferoneacetic acid and 6,7-dioxycoumarin.
(8) Derivatives of gallic acid such as, for example, digalloyl trioleate.
(9) Arylidenecycloalkanones such as, for example, benzylidenecamphor, p-tert.butylbenzylidenecamphor (preferred) and methylbenzylidenecamphor.
(10) Derivatives of anthranilic acid such as, for example, menthyl anthranilate.
(11) Hydroxyphenylbenztriazole.
The compounds listed under (2) are preferred, with 2-ethylhexyl p-methoxycinnamate being especially preferred.
The compounds of formula I are known or can be prepared according to methods known per se. Thereby, p-methoxycinnamic acid, conveniently in the form of a reactive derivative (e.g. the chloride) is esterified with the polyalcohol. Stoichiometric amounts of the acid and the alcohol are conveniently used. The acid derivative is conveniently dissolved in a solvent (e.g. a chlorinated hydrocarbon such as chloroform) and the alcohol, preferably dissolved in an amine such as dimethylaniline as the solvent, is added dropwise at a temperature of about 0-20". The mixture is thereupon preferably heated in order to complete the reaction.
The crude product is thereupon conveniently poured on to ice and purified by re-extraction and washing as well as recrystallization.
The compounds of formula I can also be prepared bytrans-esterification reactions. For this purpose, a lower alkyl ester of p-methoxycinnamic acid (e.g. the methyl or ethyl ester) is reacted with the desired polyalcohol (e.g. ethyleneglycol, glycerine etc) in the presence of a catalyst. Suitable catalysts are bases such as sodium methylate or sodium ethylate. The reaction temperataure is conveniently chosen so that the methyl or ethyl alcohol formed can be distilled off at atmospheric pressure.
The following Examples illustrate the preparation of the active ingredients and the compositions provided by the invention: A. Preparation of the active substances Example 1 100 g of p-methoxycinnamic acid chloride [prepared according to Farmacia (Bucharest) (1961)345-50; C.A. 568312 i] and 200 ml of chloroform are added to a 1 litre four-necked round flask which is fitted with a stirrer, thermometer, reflux condenser and dropping funnel. The mixture is cooled to 1 O"C and at this temperature while stirring there is allowed to drop in within 1 hour a mixture of 60.5 g of dimethylanaline and 19.1 g of propyleneglycol. The reaction is completed by heating to refluxtemperaturefor2 hours. After cooling, the mixture is poured on to ice.The mixture is taken up in 250 ml of chloroform and the dimethylaniline-HCI salt is washed out with 10% hydrochloric acid and then washed with water until it is neutral.
The solvent is evaporated and the residue (90 g of crude product) is recrystallized from acetone/water (4:1). There are obtained 50.1 g of propyleneglycol di-(p-methoxycinnamic acid) ester; m.p. 97-99"C; E310 = 46100,E= 1163.
Yield: 50.5% of theory.
Example 2 173 g of methyl-p-methoxycinnamate, 38 g of propyleneglycol, 9 of sodium methylate and 300 ml of dry xylene are added to a 1 litre round flask which is fitted with a stirrer and a tap headpiece. The mixture is warmed while stirring and resulting methanol is distilled off slowly (32 g). The mixture is held at reflux temperature for a further 5 hours. After cooling, it is neutralized with 5.5 g of acetic acid, taken up in ether and washed with water. After drying over sodium sulphate, the ether is distilled off. 177 g of crude product are obtained. After recrystallization from methanol, there is obtained propyleneglycol di-(pmethoxycinnamic acid) ester.
M.P.96-98 C.
Example 3 100 g of p-methoxycinnamic acid chloride and 200 ml of chloroform are added to a 1 lire four-necked flask which is fitted with a stirrer, thermometer, reflux condenser and dropping funnel. The mixture is cooled to 10 C and at this temperature while stirring there is allowed to drop in within 0.5 hour a mixture of 60.5 g of dimethylaniline and 15.5 g of glycerine. The reaction is completed by heating at reflux for 1 hour. After cooling, the mixture is poured on to ice. The mixture is taken up in 200 ml of chloroform and the dimethylaniline is washed out with 10% hydrochloric acid and then washed with water until it is neutral. The solvent is evaporated and the solid residue (113 g of crude product) is recrystallized from 200 ml of toluene.
There are obtained 51.1 g of glycerine tri-(p-methoxycinnamic acid) ester.
M.p. 104-1050C; e310 = 67970, E= 1187. Yield: 52.5% of theory.
Example 4 According to the process described in Examples 1 and 3, from 100 g of p-methoxycinnamic acid chloride and 37.5 g of treithyleneglycol in the presence of 60.5 g of dimethylaniline in chloroform there are obtained 81 g of triethyleneglycol di-(p-methoxycinnamic acid) ester: m.p. 82-83"C; E310 = 46900, E=995. Yield 69% of theory.
The following esters are prepared in an analogous manner: Ethyleneglycol di-(p-methoxycinnamic acid) ester; m.p. 147-149"C; E310 = 44932, E=1175.
Trimethyleneglycol di-(p-methoxycinnamic acid) ester; m.p. 140-1410C; c310 = 45150, E=1139.
1,3-Butyleneglycol di-(p-methoxycinnamic acid) ester; m.p. 97.5-99.5"C; E310 = 44780, E=1090.
2,3-Butyleneglycol di-(p-methoxycinnamic acid) ester; m.p. 154-156"C; E310 = 46260, E=127.
2-Methyl-2,4-pentanediol di-(p-methoxycinnamic acid) ester; m.p.100-101 C; E310 = 43368, E=989.
1,5-Pentanediol di-(p-methoxycinnamic acid) ester: m.p.76.5-78 C: E310 =47250,E=1115.
1,6-Hexanediol di-(p-methoxycinnamic acid) ester; m.p. 92.5-93.5"C; E310 = 47300, E=1080.
2,5-Hexanediol di-(p-methoxycinnamic acid) ester; m.p. 126.5-128.5"C; E310 = 44700, E=1020.
Diethyleneglycol di-(p-methoxycinnamic acid) ester; m.p. 77.5-78.5"C; E310 = 45000, E=1055.
B. Formulations Example 5 Sun-screen cream, semi-fatty (olw) Parts by weight (A) 4-(1 ,1 -Dimethylethyl)-4'-methoxy- dibenzoylmethane 1.5 Propyleneglycol di-(p-methoxy cinnamic acid) ester 3.0 Stearic acid triply pressed 10.0 Cetyl alcohol 1.0 Glycerine monomyristate 5.0 Isopropyl adipate 7.0 Oleyl alcohol 4.0 Methyl and propyl p-aminobenzoic acid (70/30) 0.25 (B) Diethanolamine cetyl phosphate 3.0 (C) Distilled water 59.25 Propyleneglycol 6.0 (D) Perfume q.s.
The combined components of (A) are heated to 85"C on a water-bath and thereupon (B) is added at this temperature. (C) is heated to 750C and added to (A) + (B). The resulting mixture is stirred. After cooling to 35"C, water losses are compensated where applicable and (D) is added.
Example 6 Sun-screen milk (ole) Parts by weight (A) Cetyl alcohol 2.0 Glycerine monomyristate 4.0 Arachis oil hydrogenated pharmacop. 2.0 Isopropyl adipate 5.0 Propyleneglycol di-(p-methoxy cinnamic acid) ester 2.0-5.0 (B) Diethanolamine cetyl phosphate 3.0 (C) Distilled water 74.0-68.5 Propyleneglycol 3.0 Urea 5.0 (D) Perfume q.s.
Preserving agent q.s.
The mixture (A) is heated to 85"C on a water-bath and thereupon B is added at this temperature. The combined components of (C) are heated to 75"C and thereupon added to (A) + (B). The water losses are balanced after cooling to 25-30"C and then (D) is added. The mixture is stirred further until the temperature reached 25"C.
Example 7 Sun-screen cream for athletes (woo) Parts by weight (A) Propyleneglycol di-(p-methoxy cinnamic acid) ester 1.5 4-(1,1-Dimethylethyl)-4'- methoxy-dibenzoylmethane 1.0 Sorbityl sesquioleate 9.0 Lanolin 1.0 Paraffin oil 8.0 Methyl and propyl p-aminobenzoic acid ester (70/30) 0.25 (B) Isopropyl myristate 10.0 Aluminium stearate 0.1 (C) Magnesium sulphate 0.3 Propyleneglycol 3.0 Distilled water 67.35 Perfume 0.5 The aluminium stearate is carefully mixed with the isopropyl myristate and the resulting mixture (B) is added to the combined components of (A) which are heated to 80"C. To the hot mixture (A) + (B) there is slowly added the solution (C) which is heated to 750C. (A) + (B) + (C) is left to cool while stirring.At 40"C the water losses are balanced and the perfume is added. The mixture is thereupon homogenized.
Example 8 Sun-screen oil Parts by weight Propyleneglycol di-(p-methoxy cinnamic acid) ester 4.0 Propyleneglycol dicaprylate and dicaprate 26.0 Vaseline oil (d = 0.849 - 0.866) 70.0 oil-soluble colouring substance q.s.
Perfume (0.5 - 1%) q.s.
The combined components are heated to 80"C. The mixture is thereupon cooled and perfumed.
Example 9 Sun-screen stick Parts by weight 4-( 1,1 -Dimethylethyl)-4'-methoxy- dibenzoylmethane 2.0 Propyleneglycol di-(p-methody) cinnamic acid) ester 5.0 Oleyl alcohol (Satol) 17.0 Cracked hydrogenated castor oil 19.0 Microcrystalline wax 30.0 Vaseline oil 10.0 Methyl and propyl p-aminobenzoic acid ester (70/30) 0.25 Vaseline 16.75 Perfume 0.5 The combined components are melted together and perfumed. The mixture is thereupon poured into moulds.

Claims (10)

1. A light-screen composition, which contains a compound of the formula
wherein R1 represents hydrogen of C1 ~3-alkyl, R2 represents hydrogen of C1 ~7-alkyl, X stands for the grouping (CH2)n or (CH2OCH2)p and m = 1-5, n = 0-4 and p = 1-3, in dissolved or dispersed form and, if desired, additional substances usual in light-screen compositions.
2. A light-screen composition in accordance with claim 1, wherein the content of compound of formula I in the light-screen composition amounts to 1-6 wt. %.
3. A light-screen composition according to claim 1 or claim 2, which contains propyleneglycol di-(p-methoxycinnamic acid) ester.
4. A light-screen composition according to claim 1 or claim 2, which contains 1,3-butyleneglycol di-(p-methoxycinnamic acid) ester.
5. A light-screen composition according to claim 1 or claim 2, which contains triethyleneglycol di-(p-methoxycinnamic acid) ester.
6. The use of compounds of the formula
wherein R1 represents hydrogen or C1~3-alkyl, R2 represents hydrogen of C1~7-alkyl, X stands for the grouping (-CH2-)n or (-CH20CH2-)p and m = 1-5, n = 0-4 and p = 1-3, in dissolved or dispersed form as a light-screen agent.
7. The use of propyleneglycol di-(p-methoxycinnamic acid) ester in dissolved or dispersed form as a light-screen agent.
8. The use of 1 ,3-butyleneglycol di-(p-methoxycinnamic acid) ester in dissolved or dispersed form as a light-screen agent.
9. The use of treithyleneglycol di-(p-methoxycinnamic acid) ester in dissolved or dispersed form as a light-screen agent.
10. A process for the manufacture of a light-screen composition, which process comprises incorporating a compound of the formula
wherein R1 represents hydrogen of C1 ~3-alkyl, R2 represents hydrogen or Cs ~7-alkyl, X stands for the grouping (-CH2-)n or (-CH2OCH2-)p and m = 1-5, n = 0-4 and p = 1-3, into a cosmetic base.
GB08221133A 1981-07-22 1982-07-21 Light-screen compositions Expired GB2105190B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH478381A CH648753A5 (en) 1981-07-22 1981-07-22 Light protection.

Publications (2)

Publication Number Publication Date
GB2105190A true GB2105190A (en) 1983-03-23
GB2105190B GB2105190B (en) 1985-07-17

Family

ID=4282465

Family Applications (1)

Application Number Title Priority Date Filing Date
GB08221133A Expired GB2105190B (en) 1981-07-22 1982-07-21 Light-screen compositions

Country Status (6)

Country Link
JP (1) JPS5824512A (en)
CH (1) CH648753A5 (en)
DE (1) DE3227250A1 (en)
FR (1) FR2509990B1 (en)
GB (1) GB2105190B (en)
NL (1) NL8202949A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0791353A1 (en) * 1996-02-26 1997-08-27 Shiseido Company Limited Ultraviolet absorbing composition
US20110086912A1 (en) * 2009-10-09 2011-04-14 Macgregor Alexander Derivatives of Propane Diyl Dicinnamate

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6248612A (en) * 1985-08-27 1987-03-03 Narisu Keshohin:Kk Cosmetic
US8968452B2 (en) * 2011-04-27 2015-03-03 Xerox Corporation Phase change inks containing crystalline trans-cinnamic diesters and amorphous isosorbide oligomers
US8906150B2 (en) * 2011-04-27 2014-12-09 Xerox Corporation Phase change inks containing crystalline trans-cinnamic diesters and polyterpene resins

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2190917A (en) * 1938-04-07 1940-02-20 Dow Chemical Co Ethylene dicinnamate
BE662111A (en) * 1965-04-06 1965-08-02
DE2744326A1 (en) * 1977-10-01 1979-04-12 Henkel Kgaa Antiinflammatory agents for cosmetics - esp. sunscreen compsns., comprises hydroxy-cinnamic acid ester(s)
JPS5935941B2 (en) * 1979-04-02 1984-08-31 株式会社資生堂 UV absorber
DE3175184D1 (en) * 1980-12-26 1986-09-25 Ss Pharmaceutical Co 2,3-butanediol diester derivatives, process for producing the same, and an antiulcer drug containing the same

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0791353A1 (en) * 1996-02-26 1997-08-27 Shiseido Company Limited Ultraviolet absorbing composition
US5849272A (en) * 1996-02-26 1998-12-15 Shiseido Co., Ltd. Ultraviolet absorbing composition
US20110086912A1 (en) * 2009-10-09 2011-04-14 Macgregor Alexander Derivatives of Propane Diyl Dicinnamate
US9061993B2 (en) * 2009-10-09 2015-06-23 Toronto Institute of Pharmaceutical Technology Derivatives of propane diyl dicinnamate

Also Published As

Publication number Publication date
FR2509990A1 (en) 1983-01-28
NL8202949A (en) 1983-02-16
JPS5824512A (en) 1983-02-14
FR2509990B1 (en) 1985-08-09
DE3227250A1 (en) 1983-02-10
GB2105190B (en) 1985-07-17
CH648753A5 (en) 1985-04-15

Similar Documents

Publication Publication Date Title
US4387089A (en) 4-(1,1-Dimethylethyl)-4&#39;-methoxydibenzoylmethane
CA1204779A (en) 3-benzylidene camphors; process for preparing the same and their use as protective agents against uv radiation
US4584190A (en) Novel chalcone derivatives and ultraviolet absorbers comprising the same
US4562067A (en) Preparation of novel dibenzoylmethane derivative sunscreen agents
EP0255157B1 (en) Novel sunscreen agents, sunscreen compositions and methods for preventing sunburn
US4588839A (en) Sulphonamides derived from 3-benzylidene-camphor and their application as UV filters
US4814162A (en) Cosmetic compositions containing hydroxyl derivatives of dibenzoylmethane and their use in protecting the skin against ultraviolet rays and derivatives for use therein
US4937370A (en) Novel chromophores, sunscreen compositions and methods for preventing sunburn
US4489057A (en) U.V. Absorbing cosmetic compositions
US5175340A (en) New liposoluble unsaturated benzalmalonate derivatives and their use as absorbers for ultraviolet radiation in cosmetics
US4098882A (en) Anti-solar composition
JP2675007B2 (en) New sunscreen
US5041282A (en) Method for protecting the skin from UVA and UVB rays
US3390051A (en) Dialkylaminocinnamates and dialkylbenzalmalonates in ultraviolet absorbing compositios and methods
US4584191A (en) Hair care and skin care compositions containing biotin ethyl ester
US4070450A (en) Sunscreening compound and method
US5160731A (en) Sunscreen agents, sunscreen compositions and methods for preventing sunburn
JPS6116258B2 (en)
GB2105190A (en) Light-screen compositions
US5146002A (en) Aroyl ketone derivative, uv ray absorber comprising the same, and cosmetic composition containing the same
US5191121A (en) Aroyl ketone derivative, UV ray absorber comprising the same, and cosmetic composition containing the same
US5243064A (en) Chromophores, sunscreen compositions and methods for preventing sunburn
AU587211B2 (en) Ultra violet agents
US5229106A (en) Sunscreen agents, sunscreen compositions and method for preventing sunburn
US5229107A (en) Sunscreen agents, sunscreen compositions and methods for preventing sunburn

Legal Events

Date Code Title Description
PCNP Patent ceased through non-payment of renewal fee